Heterodimerization of Mouse Orexin type 2 receptor variants and the effects on signal transduction

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 3, 2014, Pages 652-663

  Wang, Chunmei ^a   Pan, Yanyou ^a   Zhang, Rumin ^a   Bai, Bo ^a   Chen, Jing ^a,b   Randeva, Harpal S ^b  

^a JINING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

BRET; GPCR; Heterodimerization; Hypocretin (Orexin); MOX2 R; MOX2 R

Indexed keywords

CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; HETERODIMER; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; OREXIN 2 ALPHA RECEPTOR; OREXIN 2 BETA RECEPTOR; OREXIN 2 RECEPTOR; PROTEIN KINASE C INHIBITOR; PROTEIN VARIANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; DIMERIZATION; EMBRYO; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; CALCIUM; CELL LINE; CELL PROLIFERATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENETIC VARIATION; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; NEUROPEPTIDES; OREXIN RECEPTORS; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION;

EID: 84891928355     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.12.010     Document Type: Article

References (49)

1. Alvarez-Curto E., Pediani J.D., Milligan G. Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors. Anal. Bioanal. Chem. 2010, 398:167-180.
2. Ammoun S., Holmqvist T., Shariatmadari R., Oonk H.B., Detheux M., Parmentier M., Akerman K.E., Kukkonen J.P. Distinct recognition of OX1 and OX2 receptors by orexin peptides. J. Pharmacol. Exp. Ther. 2003, 305:507-514.
3. Ammoun S., Johansson L., Ekholm M.E., Holmqvist T., Danis A.S., Korhonen L., Sergeeva O.A., Haas H.L., Akerman K.E., Kukkonen J.P. OX1 orexin receptors activate extracellular signal-regulated kinase in Chinese hamster ovary cells via multiple mechanisms: the role of Ca2+ influx in OX1 receptor signaling. Mol. Endocrinol. 2006, 20:80-99.
4. Ammoun S., Lindholm D., Wootz H., Åkerman K.E.O., Kukkonen J.P. G-protein-coupled OX1 Orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress-activated protein kinase. J. Biol. Chem. 2006, 281:834-842.
5. Baldwin J.M. Structure and function of receptors coupled to G proteins. Curr. Opin. Cell Biol. 1994, 6:180-190.
6. Bulenger S., Marullo S., Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 2005, 26:131-137.
7. Cao W., Tang S., Yuan H., Wang H., Zhao X., Lu H. Mycobacterium tuberculosis antigen Wag31 induces expression of C-chemokine XCL2 in macrophages. Curr. Microbiol. 2008, 57:189-194.
8. Carrillo J.J., Pediani J., Milligan G. Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J. Biol. Chem. 2003, 278:42578-42587.
9. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
10. Chen J., Karteris E., Collins D., Randeva H.S. Differential expression of mouse orexin receptor type-2 (OX2R) variants in the mouse brain. Brain Res. 2006, 1103:20-24.
11. Chen J., Randeva H.S. Genomic organization of mouse orexin receptors: characterization of two novel tissue-specific splice variants. Mol. Endocrinol. 2004, 18:2790-2804.
12. Chen J., Randeva H.S. Genomic organization and regulation of the human orexin (hypocretin) receptor 2 gene: identification of alternative promoters. Biochem. J. 2010, 427:377-390.
13. Cottet M., Albizu L., Perkovska S., Jean-Alphonse F., Rahmeh R., Orcel H., Mejean C., Granier S., Mendre C., Mouillac B., Durroux T. Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes. Curr. Opin. Pharmacol. 2010, 10:59-66.
14. Cusack B.P., Wolfe K.H. Changes in alternative splicing of human and mouse genes are accompanied by faster evolution of constitutive exons. Mol. Biol. Evol. 2005, 22:2198-2208.
15. Cvejic S., Devi L.A. Dimerization of the δ opioid receptor: implication for a role in receptor internalization. J. Biol. Chem. 1997, 272:26959-26964.
16. De Lecea L., Sutcliffe J.G. The hypocretins/orexins: novel hypothalamic neuropeptides involved in different physiological systems. Cell. Mol. Life Sci. 1999, 56:473-480.
17. Duguay D., B Langer-Nelson E., Mongrain V., Beben A., Khatchadourian A., Cermakian N. Dynein light chain Tctex-type 1 modulates orexin signaling through its interaction with orexin 1 receptor. PLoS ONE 2011, 6:e26430.
18. Franco R., Casado V., Cortes A., Mallol J., Ciruela F., Ferre S., Lluis C., Canela E.I. G-protein-coupled receptor heteromers: function and ligand pharmacology. Br. J. Pharmacol. 2008, 153(Suppl. 1):S90-S98.
19. Grant M., Patel R.C., Kumar U. The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors. J. Biol. Chem. 2004, 279:38636-38643.
20. Guo W., Shi L., Filizola M., Weinstein H., Javitch J.A. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17495-17500.
21. Guo Y., Feng P. OX2R activation induces PKC-mediated ERK and CREB phosphorylation. Exp. Cell Res. 2012, 318:2004-2013.
22. Gupta A., Decaillot F.M., Gomes I., Tkalych O., Heimann A.S., Ferro E.S., Devi L.A. Conformation state-sensitive antibodies to G-protein-coupled receptors. J. Biol. Chem. 2007, 282:5116-5124.
23. Ida T., Nakahara K., Katayama T., Murakami N., Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res. 1999, 821:526-529.
24. Jockers R., Maurice P., Boutin J.A., Delagrange P. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?. Br. J. Pharmacol. 2008, 154:1182-1195.
25. Karteris E., Chen J., Randeva H.S. Expression of human prepro-orexin and signaling characteristics of orexin receptors in the male reproductive system. J. Clin. Endocrinol. Metab. 2004, 89:1957-1962.
26. Kearn C.S., Blake-Palmer K., Daniel E., Mackie K., Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?. Mol. Pharmacol. 2005, 67:1697-1704.
27. Korzh A., Keren O., Gafni M., Bar-Josef H., Sarne Y. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell. Brain Res. 2008, 1189:23-32.
28. Li Y., Chen J., Bai B., Du H., Liu Y., Liu H. Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction. Cell. Signal. 2012, 24:991-1001.
29. Liang Y., Woodward D.F., Guzman V.M., Li C., Scott D.F., Wang J.W., Wheeler L.A., Garst M.E., Landsverk K., Sachs G., Krauss A.H., Cornell C., Martos J., Pettit S., Fliri H. Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Br. J. Pharmacol. 2008, 154:1079-1093.
30. Liu R.J., Van Den Pol A.N., Aghajanian G.K. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci. 2002, 22:9453-9464.
31. Lubkin M., Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem. Biophys. Res. Commun. 1998, 253:241-245.
32. Lund P.E., Shariatmadari R., Uustare A., Detheux M., Parmentier M., Kukkonen J.P., Akerman K.E. The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C. J. Biol. Chem. 2000, 275:30806-30812.
33. Malendowicz L.K., Tortorella C., Nussdorfer G.G. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J. Steroid Biochem. Mol. Biol. 1999, 70:185-188.
34. Milligan G. Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. Eur. J. Pharm. Sci. 2004, 21:397-405.
35. Milligan G., Canals M., Pediani J.D., Ellis J., Lopez-Gimenez J.F. The role of GPCR dimerisation/oligomerisation in receptor signalling. Ernst Schering Found Symp Proc 2006, 145-161.
36. Nakata H., Suzuki T., Namba K., Oyanagi K. Dimerization of G protein-coupled purinergic receptors: increasing the diversity of purinergic receptor signal responses and receptor functions. J. Recept. Signal Transduct. Res. 2010, 30:337-346.
37. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., Pocius J., Michael L.H., Behringer R.R., Garry D.J., Entman M.L., Schneider M.D. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:12313-12318.
38. Okumura T., Takeuchi S., Motomura W., Yamada H., Egashira Si S., Asahi S., Kanatani A., Ihara M., Kohgo Y. Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation. Biochem. Biophys. Res. Commun. 2001, 280:976-981.
39. Overton M.C., Blumer K.J. The extracellular N-terminal domain and transmembrane domains 1 and 2 mediate oligomerization of a yeast G protein-coupled receptor. J. Biol. Chem. 2002, 277:41463-41472.
40. Sakai T., Aoyama M., Kusakabe T., Tsuda M., Satake H. Functional diversity of signaling pathways through G protein-coupled receptor heterodimerization with a species-specific orphan receptor subtype. Mol. Biol. Evol. 2010, 27:1097-1106.
41. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., Mcnulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
42. Seong J.Y., Wang L., Oh D.Y., Yun O., Maiti K., Li J.H., Soh J.M., Choi H.S., Kim K., Vaudry H., Kwon H.B. Ala/Thr(201) in extracellular loop 2 and Leu/Phe(290) in transmembrane domain 6 of type 1 frog gonadotropin-releasing hormone receptor confer differential ligand sensitivity and signal transduction. Endocrinology 2003, 144:454-466.
43. Spinazzi R., Ziolkowska A., Neri G., Nowak M., Rebuffat P., Nussdorfer G.G., Andreis P.G., Malendowicz L.K. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades. Int. J. Mol. Med. 2005, 15:847-852.
44. Takahashi N., Okumura T., Yamada H., Kohgo Y. Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats. Biochem. Biophys. Res. Commun. 1999, 254:623-627.
45. Van Den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 1998, 18:7962-7971.
46. Ward R.J., Pediani J.D., Milligan G. Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A. J. Biol. Chem. 2011, 286:37414-37428.
47. Wenzel J., Grabinski N., Knopp C.A., Dendorfer A., Ramanjaneya M., Randeva H.S., Ehrhart-Bornstein M., Dominiak P., Johren O. Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R1601-R1609.
48. Yamamoto Y., Ueta Y., Serino R., Nomura M., Shibuya I., Yamashita H. Effects of food restriction on the hypothalamic prepro-orexin gene expression in genetically obese mice. Brain Res. Bull. 2000, 51:515-521.
49. Zeng F.-Y., Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem. 1999, 274:19487-19497.